Document Detail

Medical therapy after successful percutaneous coronary revascularization.
MedLine Citation:
PMID:  10068356     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Percutaneous coronary revascularization frequently relieves angina in patients with ischemic heart disease and may obviate the need for antianginal medications. OBJECTIVE: To examine the use of antianginal medications after successful percutaneous coronary revascularization. DESIGN: Retrospective cohort study of the Mayo Clinic PTCA [percutaneous transluminal coronary angioplasty] Registry. SETTING: Tertiary care center. PATIENTS: 3831 patients who underwent successful percutaneous coronary revascularization from September 1979 through August 1997 and had not had myocardial infarction within the year before the intervention. MEASUREMENTS: Use of antianginal medications (beta-adrenergic blockers, nitrates, and calcium-channel blockers) before the intervention, at hospital discharge, and 6 months after the intervention. RESULTS: 99% of patients reported improvement in their symptoms at hospital discharge. At 6 months, 87% of patients were free of myocardial infarction, coronary bypass surgery, or additional percutaneous intervention. Compared with 66% of patients before the index intervention, only 12% of patients had severe angina at 6 months and 69% were completely free of angina. Nonetheless, at 6 months, 39% of patients were receiving beta-adrenergic blockers (preprocedure proportion, 43%; P < 0.001), 36% were receiving nitrates (preprocedure proportion, 41%; P < 0.001), and 57% were receiving calcium-channel blockers (preprocedure proportion, 50%; P < 0.001). These trends persisted for patients without hypertension and those who had complete revascularization. CONCLUSIONS: Successful percutaneous coronary revascularization did not substantially supplant the use of antianginal medications, which were commonly used despite the marked improvement in anginal status. This may reflect reluctance to alter therapy once symptoms of angina subside. Guidelines on continued medical therapy after percutaneous coronary revascularization are needed.
D Hasdai; A Lerman; D E Grill; C S Rihal; D R Holmes
Related Documents :
24568236 - Pulmonary diesel particulate increases susceptibility to myocardial ischemia/reperfusio...
19520306 - Surgical versus percutaneous revascularization of coronary artery disease in diabetic p...
10969666 - Survey of resident training in beating heart operations.
19101266 - Myocardial revascularization by left ventricular assisted beating heart is associated w...
9024916 - Course of impaired left ventricular function after acute myocardial infarction predicte...
19122166 - Left ventricular regional wall curvedness and wall stress in patients with ischemic dil...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of internal medicine     Volume:  130     ISSN:  0003-4819     ISO Abbreviation:  Ann. Intern. Med.     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-03-02     Completed Date:  1999-03-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372351     Medline TA:  Ann Intern Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  108-15     Citation Subset:  AIM; IM    
Mayo Clinic, Rochester, Minnesota 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Angina Pectoris / drug therapy*,  therapy
Angioplasty, Transluminal, Percutaneous Coronary*
Calcium Channel Blockers / therapeutic use
Cardiovascular Agents / therapeutic use*
Coronary Disease / classification,  therapy
Follow-Up Studies
Middle Aged
Nitrates / therapeutic use
Postoperative Period
Retrospective Studies
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Calcium Channel Blockers; 0/Cardiovascular Agents; 0/Nitrates

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  [The role of echotomography in minor renal traumatology].
Next Document:  Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized ad...